Abcam highlights successful execution of strategic priorities to drive shareholder value

Cambridge, england & waltham, mass.--(business wire)--abcam plc ("abcam,” "company,” "group”) (nasdaq: abcm), a global leader in the supply of life science research tools, today filed an investor presentation with the u.s. securities and exchange commission (“sec”) in connection with the extraordinary general meeting of the company (the “egm”) to be held on july 12, 2023 at 2:00pm (bst) || 9:00am (edt). the full presentation and other materials related to the egm are available at https://corpor.
ABCM Ratings Summary
ABCM Quant Ranking